))
The Power of Global Manufacturing Networks to Serve Patient Better — A Conversation with Michael Kraich of Boehringer Ingelheim
Manage episode 424223848 series 3580470
Content provided by Executive Platforms. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Executive Platforms or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
At the 2023 edition of the Biomanufacturing World Summit series we sat down with Michael Kraich, the Vice President of of Global Project & Product Management for Boehringer Ingelheim Biopharmaceuticals GmbH. The biopharmaceutical industry is at the cusp of a whole new generation of medicine while also still adjusting from the evolving business landscape of a post-pandemic world whose global supply chain faces frequent disruptions. What should companies be doing collectively and collaboratively to serve patients better? What does global footprint optimization look like when new products are coming online while established operations and logistics need to be evaluated to reduce risk and improve resiliency? What does a real partnership look like, and what is required from both parties to make it work on an ongoing basis? For all this and more, give this episode a listen!
--
Michael Kraich
VP of Global Project & Product Management
Boehringer Ingelheim Biopharmaceuticals GmbH
Dr. Michael Kraich is Vice President of Global Project & Product Management within Boehringer Ingelheim’s Biopharma Contract Development and Manufacturing Business.
Michael has more than 15 years of experience in Biopharmaceutical Development, Manufacturing, Project Management and Contracting. In his previous role he was heading the Global External Manufacturing Network of Boehringer Ingelheim’s Animal Health Business accountable for the strategic development and management of a global CMO and API supplier network. Before this, he was a member of the site leadership team of the Biopharma Site in Biberach, Germany, leading the local CMC Project Management organization dedicated to CMB customers.
--
Boehringer Ingelheim Biopharmaceuticals GmbH
Boehringer Ingelheim is a leading research-driven biopharmaceutical company and creates value through innovation in areas of high unmet medical need.
As one of the world’s largest manufacturers for biopharmaceuticals with in-depth experience in this field, the company is an industry pioneer and collaborates with top 20 pharma companies and innovative biotechs.
Boehringer Ingelheim BioXcellence™ reliably supplies innovative therapies that transform lives, today and for generations to come. We create solutions with our partners, building on our can-do attitude to improve patient health.
Our business is empowered by 5,000 dedicated and well-trained employees in development, quality and manufacturing and has access to a global manufacturing network providing the entire production chain from DNA to Fill & Finish. Our track records, both in commercial and clinical supply speak for themselves – since we started offering contract manufacturing in 1995, we have successfully brought 40 biologics to the market and have transferred and optimized more than 150 development and manufacturing projects at all stages from our customers to our facilities, as well as within our network.
While collaborating with our partners we never lose sight of the patients that depend on biopharmaceutical therapies. We offer capabilities to complement your expertise, so together we can deliver better therapies.
220 episodes
Share
